These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 12435053

  • 21. Lentivirus vectors: difficulties and hopes before clinical trials.
    Kafri T.
    Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
    [Abstract] [Full Text] [Related]

  • 22. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A, McCart JA, Keating A, Medin JA.
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [Abstract] [Full Text] [Related]

  • 23. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G, Malik P.
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [Abstract] [Full Text] [Related]

  • 24. Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells.
    Chen H, Yao H, Huang L, Shen Q, Jia W, Xue J.
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1196-201. PubMed ID: 17184501
    [Abstract] [Full Text] [Related]

  • 25. The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in beta-thalassemia patients.
    Persons DA.
    Ann N Y Acad Sci; 2010 Aug; 1202():69-74. PubMed ID: 20712775
    [Abstract] [Full Text] [Related]

  • 26. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.
    Hanawa H, Hargrove PW, Kepes S, Srivastava DK, Nienhuis AW, Persons DA.
    Blood; 2004 Oct 15; 104(8):2281-90. PubMed ID: 15198957
    [Abstract] [Full Text] [Related]

  • 27. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J.
    J Gene Med; 2005 Jun 15; 7(6):803-17. PubMed ID: 15655804
    [Abstract] [Full Text] [Related]

  • 28. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
    Céfaï D, Simeoni E, Ludunge KM, Driscoll R, von Segesser LK, Kappenberger L, Vassalli G.
    J Mol Cell Cardiol; 2005 Feb 15; 38(2):333-44. PubMed ID: 15698840
    [Abstract] [Full Text] [Related]

  • 29. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J, Persons DA.
    Curr Opin Drug Discov Devel; 2008 Mar 15; 11(2):225-32. PubMed ID: 18283610
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA.
    Hematology Am Soc Hematol Educ Program; 2009 Mar 15; ():690-7. PubMed ID: 20008255
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
    Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E.
    Hum Gene Ther; 2016 Feb 15; 27(2):148-65. PubMed ID: 26886832
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B.
    Curr Hematol Rep; 2005 Jul 15; 4(4):300-4. PubMed ID: 16009045
    [Abstract] [Full Text] [Related]

  • 37. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.
    Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA.
    Stem Cells; 2003 Jul 15; 21(1):111-7. PubMed ID: 12529558
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.